192 related articles for article (PubMed ID: 29451702)
21. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N
J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398
[TBL] [Abstract][Full Text] [Related]
23. [Clinical experience of the repeated multilevel injections of the botulinum toxin type A (abobotulinum toxin A) in the spastic forms of cerebral palsy].
Klochkova OA; Kurenkov AL; Karimova HM; Namazova-Baranova LS; Memedyarov AM; Kuzenkova LM; Bursagova BI
Vestn Ross Akad Med Nauk; 2014; (9-10):57-63. PubMed ID: 25816644
[TBL] [Abstract][Full Text] [Related]
24. Best clinical practice in botulinum toxin treatment for children with cerebral palsy.
Strobl W; Theologis T; Brunner R; Kocer S; Viehweger E; Pascual-Pascual I; Placzek R
Toxins (Basel); 2015 May; 7(5):1629-48. PubMed ID: 25969944
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement.
Love SC; Novak I; Kentish M; Desloovere K; Heinen F; Molenaers G; O'Flaherty S; Graham HK;
Eur J Neurol; 2010 Aug; 17 Suppl 2():9-37. PubMed ID: 20633177
[TBL] [Abstract][Full Text] [Related]
26. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
[TBL] [Abstract][Full Text] [Related]
27. Botulinum neurotoxin treatment in children with cerebral palsy: a population-based study in Norway.
Elkamil AI; Andersen GL; Skranes J; Lamvik T; Vik T
Eur J Paediatr Neurol; 2012 Sep; 16(5):522-7. PubMed ID: 22325829
[TBL] [Abstract][Full Text] [Related]
28. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.
Bekkers S; Pruijn IMJ; Van Hulst K; Delsing CP; Erasmus CE; Scheffer ART; Van Den Hoogen FJA
Dev Med Child Neurol; 2020 Jul; 62(7):861-867. PubMed ID: 32149393
[TBL] [Abstract][Full Text] [Related]
29. Functional improvement of young children with cerebral palsy treated with integrated/intensive rehabilitation and botulinum toxin injections.
Bonikowski M; Chrościnska-Krawczyk M; Pyrzanowska W
Neurol Neurochir Pol; 2023; 57(2):183-188. PubMed ID: 36537370
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
31. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
Yap R; Majnemer A; Benaroch T; Cantin MA
Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.
Thorley M; Donaghey S; Edwards P; Copeland L; Kentish M; McLennan K; Lindsley J; Gascoigne-Pees L; Sakzewski L; Boyd RN
BMC Pediatr; 2012 Aug; 12():120. PubMed ID: 22873758
[TBL] [Abstract][Full Text] [Related]
33. [Development of motor functions and manual abilities in pediatric patients with spastic cerebral palsy after botulinum toxin treatment and complex rehabilitation].
Klochkova OA; Kurenkov AL; Namazova-Baranova LS; Mamed'iarov AM; Zherdev KV
Vestn Ross Akad Med Nauk; 2013; (11):38-48. PubMed ID: 24640730
[TBL] [Abstract][Full Text] [Related]
34. Radiological outcome of reconstructive hip surgery in children with gross motor function classification system IV and V cerebral palsy.
Zhang S; Wilson NC; Mackey AH; Stott NS
J Pediatr Orthop B; 2014 Sep; 23(5):430-4. PubMed ID: 24950105
[TBL] [Abstract][Full Text] [Related]
35. Changes in Muscle Mass after Botulinum Toxin Injection in Children with Spastic Hemiplegic Cerebral Palsy.
Lee D; Kim J; Oh JY; Han MH; Kim DY; Kang JH; Jang DH
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33919735
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
Dai AI; Aksoy SN; Demiryürek AT
J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
[TBL] [Abstract][Full Text] [Related]
37. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy.
Intiso D; Simone V; Di Rienzo F; Iarossi A; Pazienza L; Santamato A; Maruzzi G; Basciani M
NeuroRehabilitation; 2014; 34(3):515-22. PubMed ID: 24473245
[TBL] [Abstract][Full Text] [Related]
38. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
Langdon K; Blair E; Davidson SA; Valentine J
Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
[No Abstract] [Full Text] [Related]
39. Ketamine-based procedural sedation and analgesia for botulinum toxin A injections in children with cerebral palsy.
Chow C; Choong CT
Eur J Paediatr Neurol; 2016 Mar; 20(2):319-322. PubMed ID: 26640079
[TBL] [Abstract][Full Text] [Related]
40. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
